Background Preliminary evidence from the COVID-19 pandemic shows the presence of
health disparities, especially in terms of morbidity and mortality. This study aimed to …

The pandemic of COVID-19 (Coronavirus Disease-2019) is an extremely contagious
respiratory illness due to a novel coronavirus, SARS-CoV-2. Certain drugs have several …

Background The COVID-19 pandemic conditions are still prevalent in Iran and other
countries and the monitoring system is gradually discovering new cases every day …

Background COVID19 is a respiratory disease caused by a novel coronavirus. As there has
been no definitive treatment for the disease so far, the only way to control the spread is to …

Viral respiratory infections are very common and they are frequently eliminated from the
body without any detrimental consequences. Secondary serious bacterial infection has been …

Abstract Background and Objective The world is currently experiencing the Coronavirus
Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive treatment of …

Background. To investigate the association between interleukins (IL‐1β, IL‐2, IL‐4, IL‐6, IL‐
8, and IL‐10) and the disease severity of coronavirus disease 2019 (COVID‐19). Materials …

Objective: Rare disease Background: Acute hemorrhagic necrotizing encephalitis (AHNE) is
a rare manifestation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has threatened patients,
healthcare systems, and all countries across the globe with unprecedented challenges and …

The latest threat to global health is the form of the ongoing Coronavirus Disease 2019
(COVID-19) pandemic. This new coronavirus (SARS-COV-2) started as a local outbreak in …